AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Vglipt-M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Curega Healthcare Pvt Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vglipt-M 500mg/50mg Tablet

Combipas 500mg/50mg tablets combine two medications to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Combipas 500mg/50mg may be used independently or in conjunction with other antidiabetic therapies. Optimal results require adherence to a balanced diet and regular physical activity. Dosage is personalized, considering individual health status, glucose readings, and other concurrent medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing maximizes efficacy; discontinuation should only occur under medical supervision. Effective blood sugar control lessens the risk of future complications. Continued adherence to your doctor's dietary and exercise plan is vital. Lifestyle significantly impacts diabetes management. Commonly reported adverse effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, particularly when used with insulin or sulfonylureas; proper recognition and management are crucial. This medication isn't universally suitable. Prior to commencing treatment, disclose any history of kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Inform your physician of all medications to ensure safety, as drug interactions are possible. Alcohol should be limited due to its potential to lower blood glucose levels. Your physician will monitor renal function and blood glucose levels throughout treatment.

Uses of Vglipt-M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vglipt-M 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vglipt-M 500mg/50mg Tablet should be administered with a meal.

Common Side effects of Vglipt-M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vglipt-M 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vglipt-M 500mg/50mg tablet should be administered with a meal.

How Vglipt-M 500mg/50mg Tablet works:

The tablet Vglipt-M, containing 500mg/50mg of a dual antidiabetic medication, combines two distinct agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Vglipt-M 500mg/50mg Tablet use poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Vglipt-M 500mg/50mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Vglipt-M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Individuals with kidney impairment should exercise caution when using Vglipt-M 500mg/50mg tablets. Dosage modification may be necessary; physician consultation is recommended.

LiverLiverUNSAFE

Use of Vglipt-M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Seek medical advice before use.

What if you forget to take Vglipt-M 500mg/50mg Tablet :

Should you forget to take a Vglipt-M 500mg/50mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vglipt-M 500mg/50mg Tablet

LabelValue
Developing Good Habits No.
Treatment Category Diabetes Management

FAQs on Vglipt-M 500mg/50mg Tablet

Vglipt-M 500mg/50mg tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate caloric intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a quick-acting sugar source like glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vglipt-M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or signs of dehydration (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Consult your doctor before taking any other medication.
Vglipt-M 500mg/50mg Tablets are contraindicated in patients with allergies to any ingredient. This medication is also harmful for those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Vglipt-M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA), is a potential, though rare, side effect of Vglipt-M 500mg/50mg Tablet. This risk is heightened in individuals with kidney disease, the elderly, and heavy alcohol users, hence its avoidance in these groups. Symptoms can include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should any of these occur, discontinue Vglipt-M 500mg/50mg Tablet immediately and seek urgent medical attention.
Prolonged use of Vglipt-M 500mg/50mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Using Vglipt-M 500mg/50mg Tablet as directed by your doctor is safe. However, even with correct dosage, common side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and hypoglycemia (low blood sugar, especially if used with insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Vglipt-M 500mg/50mg Table...
85
MRP 98
13% off